UniConnect Inks First Clinical MDx Deal in Europe with Vivia Biotech
May 31st, 2011UniConnect Inks First Clinical MDx Deal in Europe with Vivia Biotech
UniConnect , a laboratory information management system software company, announced recently that personalized medicine firm Vivia Biotech will use its UniFlow software to manage patient samples and drug compounds.
Read more on GenomeWeb News
Colleagues try to belittle my work
Dear Fiona, I’m employed within the civil service and enjoy my work but am being treated like I’m a nobody by two colleagues. Related Stories I’m 83 and bored. What activities can I do? How can I get to know my new colleagues? I think I’m falling for bloke in a big way I have to ‘give in’ to live in I can’t compete with work alpha males
Read more on Belfast Telegraph
Posted in Alternative Healing | 
Tags: Biotech, Clinical, Deal, Europe, First, Inks, UniConnect, Vivia
- AdSpecs Free Link Exchange
- Alternative Healing .edu
- Alternative Healing Crystals
- Aura Healing Crystals Chakra Balancing
- Aura Healing Journal
- Aura Healing with Crystals
- BizSiteInc – Affiliate Business Opportuities Reviews
- Canary Furniture Christchurch
- Classic Car Storage Christchurch
- Fraud Protection Advice Portal
- Healthy Energy Supplements
- Hexagon Water New Zealand
- How To Get Advice Answers Better Bigger Larger Dating More Tips Pregnant Rid of
- Lockup Storage Units Storage Christchurch
- Mortgage Debt Reduction & Insurance Savings
- MyUltimateBiz – Work from Home Opportunities
- Super Call Saver Telecommunications Savings Portal
- Used Furniture Christchurch
- FDA Advisers Back Weight-Loss Drug Qnexa
(HealthDay)HealthDay - WEDNESDAY, Feb. 22 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel gave its blessing Wednesday to a highly anticipated weight loss pill that had been rejected by health advisers once before. […]
- U.S. advisers back experimental obesity pill
(Reuters)Reuters - Experimental obesity drug Qnexa won the backing of U.S. health advisors on Wednesday, raising hopes for approval of the first prescription weight-loss pill in 13 years. […]
- FDA panel gives nod to Vivus obesity drug
(Reuters)Reuters - An experimental obesity drug from Vivus Inc won a U.S. panel's support on Wednesday, raising hopes regulators would approve a weight-loss pill for the first time in 13 years. […]
- FDA Weighs Fate of Qnexa for Weight Loss, Again
(HealthDay)HealthDay - WEDNESDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug Administration plans to take a second look at the weight loss pill Qnexa on Wednesday, after initially rejecting it because of concerns about heart problems and possible birth defects. […]
- New Weight-Loss Equation: Researchers Determine Key Calorie Cutoff
(LiveScience.com)LiveScience.com - VANCOUVER — Weight loss is not as simple as eating less and exercising more, and for those who struggle to shed the pounds, a new equation may offer some help. […]